Transfection Technologies Market 2026 growing toward $1.99 billion by 2030

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Transfection Technologies Market During 2026–2030?

The market for transfection technologies has demonstrated robust growth in recent years. It is projected to expand from $1.31 billion in 2025 to $1.42 billion by 2026, achieving a compound annual growth rate (CAGR) of 8.8%. Historically, this expansion can be ascribed to several factors, including the increasing scope of molecular biology research, advancements in gene expression investigations, a rise in protein production demands, enhanced financial support for genomics research, and its initial integration within academic laboratories.

The transfection technologies market size is anticipated to experience substantial growth in the approaching years. It is projected to expand to $1.99 billion by 2030, demonstrating an 8.7% compound annual growth rate (CAGR). The expansion observed during the forecast period can be attributed to several factors including the rise of cell and gene therapies, the increasing pipelines for RNA therapeutics, growing investment within life sciences research, the demand for efficient transfection reagents, and the broadening reach of personalized medicine. Significant trends expected in the forecast period encompass a rising need for gene editing research tools, the increased development of RNA-based therapeutics, more widespread application in cell and gene therapy, advancements in academic and biomedical research, and progress in non-viral transfection methods.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

Which Major Factors Are Driving The Expansion Of The Transfection Technologies Market?

The expansion of gene therapy is anticipated to boost the growth of the transfection technologies market in the future. Gene therapy involves a method focused on treating or preventing illnesses through genetic modification, encompassing the insertion, repair, or substitution of defective genes. The increased prevalence of gene therapy stems from advancements in genetic research, improved delivery techniques, and its capacity to address genetic conditions that were formerly untreatable. Transfection technologies play a vital role in gene therapy by enabling the accurate, secure, and efficient introduction of genetic material into cells. These technologies enable both temporary and lasting alterations to the genome, which are fundamental for addressing genetic diseases and various cancers. An example of this trend is that in December 2024, the American Society of Gene & Cell Therapy (ASGCT), a US-based non-profit medical and scientific organization, reported that the Food and Drug Administration (FDA) sanctioned six gene therapy products in 2023, an increase from five approvals in 2022. Consequently, the expanding field of gene therapy is a key driver for the growth of the transfection technologies market.

How Are The Various Segments Of The Transfection Technologies Market Categorized?

The transfection technologies market covered in this report is segmented –

1) By Product: Kits And Reagents, Equipment, Other Products

2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods

3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications

4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:

1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents

2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment

3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

What Trends Are Affecting The Expansion Of The Transfection Technologies Market?

Leading firms within the transfection technologies market are concentrating on creating sophisticated technologies, like mechanoporation transfection systems, to support more intricate and customized uses in both scientific investigation and medical treatments. These mechanoporation systems utilize mechanical forces to form transient openings in cell membranes, thereby facilitating the entry of genetic material into cells. This approach is both efficient and causes minimal invasion, which helps maintain superior cell viability. As an illustration, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, introduced CellPore, a novel transfection system. The CellPore system comprises a benchtop device and the CellPore Transfection Kit 300, which is supplied with a specialized reagent kit and disposable delivery cartridges. Employing controlled, swift deformation within microfluidic channels, CellPore proficiently delivers small molecules, nucleic acids, proteins, and gene editing complexes into cells, guaranteeing minimal cellular disturbance and robust viability. Such attributes are crucial for advancing scientific research and fostering the creation of advanced cell and gene therapies.

Which Major Firms Influence Developments In The Transfection Technologies Market?

Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Read the full transfection technologies market report here:

https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Which Region Currently Holds The Largest Share Of The Transfection Technologies Market?

North America was the largest region in the transfection technologies market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Transfection Technologies Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Browse Through More Reports Similar to the Global Transfection Technologies Market 2026, By The Business Research Company

Transfection Reagents And Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/transfection-reagents-and-equipment-global-market-report

Gene Delivery Technologies Market Report 2026

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Sterilization Equipment And Disinfectants Market 2026

https://www.thebusinessresearchcompany.com/report/sterilization-equipment-and-disinfectants-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795